By one FDA scientist’s estimate, the diabetes drug Avandia may have “caused 47,000 more diabetics to suffer heart failure, stroke or death than would have been the case if they had taken an alternative.” Yet the FDA recently decided to keep the drug on the market. What’s going on? TIME’s Massimo Calabresi has a must-read story in the next issue, which you can read online here.
(Though I will say that this week’s issue, in the iPad, paper version, is a particularly good one, with a story about Jonathan Franzen and his new novel, Freedom, on the cover.)